Indaptus Therapeutics News

Indaptus Therapeutics | DEFA14A: Others

Apr 26 09:08 ET

Indaptus Therapeutics | DEF 14A: Definitive information statements

Apr 26 09:03 ET

Indaptus Therapeutics | 8-K: Current report

Mar 25 08:33 ET

Indaptus Therapeutics | 424B5: Prospectus

Mar 13 17:05 ET

Indaptus Therapeutics | 10-K: Annual report

Mar 13 08:03 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Mar 13 08:03 ET

Indaptus Therapeutics | 8-K: Current report

Mar 4 11:05 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Newman Michael James

Jan 23 00:00 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meckler Jeffrey A

Jan 23 00:00 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sassi Nir

Jan 23 00:00 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Waltzman Roger J.

Jan 23 00:00 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Linscott Walt Addison

Jan 23 00:00 ET

Indaptus Therapeutics | 8-K: Current report

Jan 23 00:00 ET

Indaptus Therapeutics: Q3 2023 Earnings Report

Nov 6, 2023 16:06 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 6, 2023 16:05 ET

Indaptus Therapeutics | 8-K: Current report

Nov 6, 2023 08:13 ET

Indaptus Therapeutics | 8-K: Current report

Oct 31, 2023 09:12 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Anderson Glen R.

Aug 16, 2023 18:01 ET

Indaptus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Glen R. Anderson(14.17%)

Aug 16, 2023 17:57 ET

Indaptus Therapeutics | 10-Q: Q2 2023 Earnings Report

Aug 14, 2023 08:15 ET